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Objectives: The antistaphylococcal pyrrolobenzodiazepine dimer ELB-21 forms multiple adducts with duplex
DNA through covalent interactions with appropriately spaced guanine residues; it is now known to form inter-
strand and intrastrand adducts with oligonucleotide sequences of variable length. We determined the DNA
sequence preferences of ELB-21 in relation to its capacity to exert a bactericidal effect by damaging DNA.
Methods: Formation of adducts by ELB-21 and 12- to 14-mer DNA duplexes was investigated using ion-pair
reversed phase liquid chromatography and mass spectrometry. Drug-induced changes in gene expression
were measured in prophage-free Staphylococcus aureus RN4220 by microarray analysis.
Results: ELB-21 preferentially formed intrastrand adducts with guanines separated by three nucleotide base pairs.
Interstrand and intrastrand adducts were formed with duplexes both longer and shorter than the preferred target
sequences. ELB-21 elicited rapid bactericidal effects against prophage-carrying and prophage-free S. aureus strains;
cell lysis occurred following activation and release of resident prophages. Killing appeared to be due to irreparable
damage to bacterial DNA and susceptibility to ELB-21 was governed by the capacity of staphylococci to repair
DNA lesions through induction of the SOS DNA damage response mediated by the RecA-LexA pathway.
Conclusions: Thedatasupport the contention that ELB-21arrestsDNA replication, eliciting formationof ssDNA-RecA
filaments that inactivate LexA, the SOS repressor, and phage repressors such as Cl, resulting in activation of the DNA
damage response and de-repression of resident prophages. Above the MIC threshold, DNA repair is ineffective.
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Introduction
ELB-21 (Figure 1) is a pyrrolo[2,1-c][1,4]benzodiazepine (PBD)
dimer that shows potent in vitro bactericidal activity against a
wide range of Gram-positive clinical isolates, including
methicillin-resistant strains of Staphylococcus aureus (MRSA)
and vancomycin-resistant enterococci (VRE).1 This symmetrical
agent belongs to a class of molecules that binds in a sequence-
selective manner the minor groove of the DNA helix and cross-
links opposing DNA strands by forming covalent bonds with
appropriately separated guanine residues.2–4 The five-carbon
diether linking the PBD units (Figure 1) facilitates preferential
interstrand binding to 5′-Pu-GATTC-Py and 5′-Pu-GAATC-Py base-
pair sequences (Pu, purine; Py, pyrimidine; reactive guanines
shown in bold). Recently DNA footprinting studies using sub-
strates containing symmetrical hexanucleotide sequences
enabled the identification of further high-affinity binding sites:
5′-GAATTC-3′, 5′-GTTAAC-3′ and 5′-GTATAC-3′, flanked by a Pu at
the 5′ and a Py at the 3′ end.3 In addition, a number of intra-
strand binding sites were identified that may also block DNA
replication and contribute to the potent antistaphylococcal
profile of ELB-21. These sequences, which were not predicted
from initial molecular modelling studies,5 included short
(5′-GATG-3′) and extended (5′-GTTAACCG-3′) flanked targets.
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These observations increased the number of potential DNA
binding sites within the genome of the nosocomial MRSA
isolate EMRSA-16 to around 40000.3 As the footprinting sub-
strates were designed to investigate binding to the preferred
interstrand sequences,6 the genomes of target Gram-positive
bacteria could contain further as-yet-unidentified interstrand
and intrastrand binding sites.
At supra-inhibitory concentrations, ELB-21 elicited potent bac-
tericidal activity against MRSA and VRE isolates, with a greater
than 4 log reduction in viability over a 2 h period;1 DNA extracted
from ELB-21-treated MRSA was cross-linked, as evidenced by
substantial increases in DNA melting temperature and increased
molecular weight of DNA adducts identified by Southern blot
analysis.7 Exposure of EMRSA-16 to subinhibitory concentrations
of ELB-21 resulted in up-regulation of more than 160 genes in
both the logarithmic and stationary phases of bacterial
growth3 and, surprisingly in view of the capacity of PBD dimers
to prevent DNA strand separation and transcription initiation,8
twofold or greater down-regulation of only 16 genes. Almost
half of the genes affected by ELB-21 were induced prophage
genes associated with the resident S. aureus prophages wSa2
and wSa3. All sequenced S. aureus strains, with the exception
of COL, carry wSa3; wSa2 is integrated into the EMRSA-16
genome.9 Genes associated with the staphylococcal pathogen-
icity island SaPI4 were also up-regulated, as were genes indica-
tive of a DNA damage (SOS) response; 10 genes, including
those encoding the LexA repressor, recombinase A, topoisom-
erase and nucleotide excision repair proteins, were modulated
by ELB-21. Transcriptional and proteomic analysis provided
little evidence that ELB-21 selectively down-regulated genes
involved in key cellular functions or bacterial pathogenicity.3
The SOS response in S. aureus has been characterized using
non-selective DNA interactive agents such as mitomycin C
(MMC), an anti-tumour antibiotic with substantial anti-
staphylococcal activity.10,11 MMC produces intrastrand and inter-
strand cross-links in addition to monofunctional alkyl lesions in
DNA12 and at supra-inhibitory concentrationsmodulates the tran-
scriptional expression of a large number of S. aureus genes.13
Although the SOS response elicited by subinhibitory concen-
trations of ELB-21 appears to be more restricted than that associ-
ated with MMC, both induce prophage into the lytic cycle with
concomitant release of phage particles.14 Indeed, the
prophage-inducing capacity of MMC has been extensively
exploited to obtain prophages from the lysogenized host.15–17
As PBD dimers bind selectively within the minor groove of duplex
DNA, theymay have the potential to target sequences in bacterial
genes with essential housekeeping functions or to inhibit the tran-
scription of genes necessary for bacterial pathogenesis.
Our recent finding that PBD dimers form intrastrand as well as
interstrand adducts with DNA3,18 adds a further layer of com-
plexity to the interaction of these agents with staphylococcal
cells. As interstrand cross-links appear to be more stable than
intrastrand covalent adducts,18 we determined the binding kin-
etics of ELB-21 for a range of cross-linking sequences, differing
in the position of the two reactive guanine bases, using an
assay that combines high-performance liquid chromatography
and mass spectrometry (HPLC/MS)19 to shed light on the oligo-
nucleotide binding preferences of the molecule. The induction
of a large number of prophage genes by ELB-21 may mask
more subtle changes in bacterial transcription; we therefore
examined the effects of ELB-21 and MMC on gene expression
in a S. aureus strain cured of prophages to better compare the
core response at subinhibitory concentrations of these drugs.
The data demonstrate a comparable and restricted transcrip-
tional response to these two agents. The lytic, but not bacteri-
cidal, activity of ELB-21 appears to be due solely to activation
of resident prophages within target bacteria. We conclude that
ELB-21 displays a complex DNA binding profile that elicits a
general DNA damage response in staphylococci comparable to
MMC; the PBD dimer preferentially forms DNA intrastrand com-
plexes by virtue of covalent interactions with appropriately
spaced guanine residues.
Materials and methods
Bacterial strains, culture and antibacterial agents
S. aureus EMRSA-16 is a MRSA isolate from the Royal Free Hospital
(London, UK). S. aureus RN4220, a derivative of NCTC 8325 cured of all
prophages,20,21 was the gift of Friedrich Go¨tz (University of Tu¨bingen,
Germany). S. aureus RN981 and RN1030 are recA2 mutants derived
from, respectively, RN450 and RN451; RN450 (8325-4) is a prophage-free
derivative of NCTC 8325 and RN451 is RN450 but lysogenic for f11.22,23
RN450, RN451, RN981 and RN1030 were kindly provided by Jose´
Penade´s (Instituto Valenciano de Investigaciones Agrarias, Segorbe,
Spain). Bacteria were grown in Mueller-Hinton (MH) broth (Oxoid) or
on MH agar plates at 378C. The PBD dimer ELB-21 was obtained from
Spirogen Ltd. (London, UK) and was synthesized as described.4 MMC
was obtained from Sigma (Poole, UK). MICs were determined by the
CLSI (formerly NCCLS) broth microplate assay as previously described.7
For MIC determination, agents were dissolved in DMSO prior to dilution
in broth; at the concentrations used, the solvent had no effect on
bacterial growth. For cross-linking studies, ELB-21 was maintained as
a 3 mM stock solution in 50/50 v/v methanol/water at 2208C for no
longer than 4 months. Working solutions of 200 mM were prepared by
diluting stock solution with nuclease-free water; these were stored
at 2208C for no more than 1 week. Lytic phage particles in bacterial
cultures were enumerated using the soft agar overlay method21 and
RN450 as indicator strain.
Transmission electron microscopy
Phages were fixed in 1.5% glutaraldehyde for at least 2 h at room temp-
erature, treated with osmium tetroxide and embedded in epoxy resin.
Sectioning and staining with uranyl acetate was followed by Reynolds’
lead citrate. Ultrathin sections were viewed and photographed using a
Philips 201 transmission electron microscope.
Microarray analysis
Total bacterial RNA was purified from each sample, labelled and hybri-
dized to the BmG@S SAv1.1.0 microarray as described previously.3 This
array has been described elsewhere24 and contains PCR products repre-
senting all predicted open reading frames from the initial seven
S. aureus genome sequencing projects. The array design is available in
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Figure 1. Structure of the pyrrolobenzodiazepine dimer ELB-21.
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BmG@Sbase (accession number: A-BUGS-17; http://bugs.sgul.ac.uk/
A-BUGS-17) and also ArrayExpress (accession number: A-BUGS-17).
Hybridization data were analysed using an Affymetrix 428 scanner
then quantified using Bluefuse for Microarrays 3.5 software (BlueGnome).
Data analysis was performed in GeneSpring GX 7.3 (Agilent Technologies)
using median-normalized Cy5/Cy3 ratio intensities for three biological
replicates. Only genes whose expression ratio showed at least a
twofold difference with a Benjamini and Hochberg false discovery rate
≤0.05% in the presence of ELB-21 were regarded as being significantly
different from the control. Fully annotated microarray data have been
deposited in BmG@Sbase (accession number E-BUGS-115 http://bugs.
sgul.ac.uk/E-BUGS-115) and also ArrayExpress (accession number
E-BUGS-115).
Quantitative RT–PCR (qRT–PCR)
qRT–PCR was performed as described previously.3 Gene-specific primer
pairs were designed for S. aureus RN4220 genes of interest to yield ampli-
cons of 100–150 bp and the oligonucleotides used are listed in Table S1
(available as Supplementary data at JAC Online). Data shown are the
median of three biological and two technical replicates; each replicate
was performed in duplicate.
Kinetics of covalent binding of drug to dsDNA
The interaction of ELB-21 and short (12- to 14-mer) oligonucleotides
incorporating putative binding sites was investigated using a combination
of ion-pair reversed phase liquid chromatography (RPLC) and mass spec-
trometry (MS) as described earlier.18,19 Sequences of the single-stranded
(ss) oligonucleotides used are given in Table 1 and were obtained in lyo-
philized form from AtdBio Ltd. (Southampton, UK). They were annealed to
form dsDNA: each oligonucleotide was dissolved in 100 mM CH3COONH4
to give a 2 mM stock solution that was diluted in annealing buffer
(10 mM Tris, 50 mM NaCl, 1 mM EDTA pH 8.5) immediately prior to
annealing to give a 1 mM DNA solution. The complementary ssDNA
sequences were held at 708C for 10 min, allowed to cool slowly and
then kept at 2208C overnight to ensure completion of the annealing
process; dsDNA duplex solutions were adjusted to a DNA concentration
of 50 mM with 20 mM CH3COONH4 prior to use. Ligand-DNA complexes
were prepared by incubating ELB-21 with ss or duplex oligonucleotides
at a molar ratio of 4:1 and the reactions followed at room temperature.
RPLC was performed on a Thermo Electron HPLC system incorporating
a 4.6×50 mm Xterra MS C18 column packed with 2.5 mM particles
(Waters Ltd., Elstree, UK). A gradient system of 100 mM triethyl
ammonium bicarbonate as buffer A and 40% acetonitrile in water
(HPLC grade, Fisher Scientific UK) as buffer B were used. The gradient
was ramped from 90% buffer A at 0 min to 50% buffer A at 20 min
and finally to 10% buffer A at 35 min. UV absorbance was monitored
at 254 nm and fractions containing separated components were col-
lected manually, combined as appropriate, lyophilized and analysed by
matrix assisted laser desorption time-of-flight mass spectrometry
(MALDI-TOF MS): covalently bound DNA-ELB-21 adduct samples were
prepared by diluting with matrix (37 mg 2′,4′,6′-trihydroxyacetophenone
in 1 mL acetonitrile, 45 mg ammonium citrate in 1 mL water – mix 1:1
for matrix) either 2:1, 1:1 or 1:5 (sample:matrix), then 1 mL of sample
was spotted onto the MALDI target plate and allowed to dry. Samples
were analysed with an Applied Systems Voyager-DE Biospectrometry
Workstation MALDI-TOF mass spectrometer with a nitrogen laser in posi-
tive linear mode using delayed extraction (500 ns) and an accelerating
voltage of 25000 V. Acquisition was between 4000 and 15000 Da with
100 shots/spectrum.
Results
Formation of covalent adducts with ds oligonucleotides
Predictive modelling and DNA cross-linking and footprinting
studies2,5 have indicated that the preferred interstrand binding
sites for ELB-21 are 5′-Pu-GATTC-Py and 5′-Pu-GAATC-Py, but
more recent work3 has identified further interstrand targets as
well as at least 10 potential intrastrand sites comprising 2 to 6
bases separating same-strand guanines. To establish the prefer-
ences for ELB-21 covalent adduct formation with DNA we inves-
tigated real-time covalent binding of the drug to the DNA
duplexes shown in Table 1; these duplexes incorporate the
major interstrand and intrastrand sites identified by our previous
work.3
The formation of interstrand cross-links within the 5′-Pu-
GAATC-Py sequence was investigated using the 13-mer oligonu-
cleotide duplex-1 (Table 1). RPLC analysis of the annealed
duplex formed from the ss sequences Seq-1 and Seq-2
(Table 1) resulted in two peaks with retention times (RTs) of
27.1 min and 27.5 min (Figure 2a), equivalent to denatured
Seq-1 and Seq-2 as determined by MALDI-TOF MS and consistent
with our previous finding that short dsDNA duplexes denature
Table 1. Single-strand (ss) and double-strand (ds) oligonucleotides designed as substrates for RPLC-MS investigations of DNA:drug adduct formation
Label ssDNA Sequence
Average
mass (Da) Label dsDNA Sequence
Average
mass (Da)
ELB-21:dsDNA
adduct mass (Da)
Seq-1 5′-TATAGAATCTATA-3′ 3956.5 Duplex-1 5′-TATAGAATCTATA-3′ 7904.1 8516.8
Seq-2 5′-TATAGATTCTATA-3′ 3946.6 3′-ATATCTTAGATAT-5′
Seq-3 5′-TATAGAATGTATA-3′ 3996.6 Duplex-2 5′-TATAGAATGTATA-3′ 7904.1 8516.8
Seq-4 5′-TATACATTCTATA-3′ 3906.5 3′-ATATCTTACATAT-5′
Seq-5 5′-TATAGATCTATA-3′ 3643.7 Duplex-3 5′-TATAGATCTATA-3′ 7287.4 7900.1
3′-ATATCTAGATAT-5′
Seq-6 5′-TATAGATGTATA-3′ 3683.4 Duplex-4 5′-TATAGATGTATA-3′ 7286.7 7899.5
Seq-7 5′-TATACATCTATA-3′ 3603.4 3′-ATATCTACATAT-5′
Seq-8 5′-TATAGAAATCTATA-3′ 4269.9 Duplex-5 5′-TATAGAAATCTATA-3′ 8522.05 9106.66
Seq-9 5′-TATAGATTTCTATA-3′ 4251.9 3′-ATATCTTTAGATAT-5′
Seq-10 5′-TATAGAAATGTATA-3′ 4309.9 Duplex-6 5′-TATAGAAATGTATA-3′ 8522.05 9106.66
Seq-11 5′-TATACATTTCTATA-3′ 4211.8 3′-ATATCTTTACATAT-5′
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under the HPLC conditions used. Immediately following mixing of
duplex-1 and ELB-21, a major adduct peak (RT 30.9 min) was
apparent (Figure 2b), confirmed by MALDI-TOF MS as the 1:1
ELB-21/Seq-1/Seq2 duplex interstrand cross-linked adduct and
representing approximately 70% of the DNA in the sample. A
minor (,10%) peak (RT 33.7 min) was also observed and was
identified as the ELB-21/Seq-1 ssDNA adduct; its abundance
declined over time. Further incubation determined that inter-
strand 5′-Pu-GAATC-Py adduct formation was complete (95%)
within 3 h (Figure 2c and d).
As we have obtained evidence that ELB-21 may form intra-
strand cross-links,3 we investigated the potential for intrastrand
adduct formation using duplex-2 (Table 1); this duplex differs
from duplex-1 with respect to replacement of 9-cytosine with
a guanine residue on the 5′ strand, yielding 5′-Pu-GAATG-Py.
Analysis of the annealed duplex under RPLC conditions revealed
two peaks (RT 27.1 min and RT 28.2 min), confirmed by MALDI-
TOF MS to be Seq-3 and Seq-4, respectively (Figure 3a). A pro-
minent peak was apparent at RT 29.8 min immediately (0 h)
after mixing of ELB-21 and duplex-2 (Figure 3b), confirmed by
MALDI-TOF MS as the 1:1 ELB-21/Seq-3/Seq-4 duplex adduct.
During the time course of these experiments, two further
peaks emerged at RT 34.2 min and RT 36.3 min (Figure 3b–d),
although the RT 29.8 min peak remained prominent throughout
and accounted for 90% of the adducts formed at completion.
Adduct formation with 5′-Pu-GAATG-Py progressed very rapidly
and was complete within 1 h (Figure 3c). Even at 0 h, it was
noticeable that that the ratio of the unreacted oligonucleotides
Seq-3 and Seq-4 changed in favour of Seq-4, indicating prefer-
ential ELB-21 reactivity with the 5′-Pu-GAATG-Py-containing
strand Seq-3 (Figure 3b). The chromatograms indicated that
ELB-21 initially formed the duplex intrastrand cross-linked RT
29.8 min adduct with the Seq3/Seq-4 duplex, consuming both
ssDNA species at an equal rate. However, in contrast to the
duplex-1 interstrand cross-linked adduct, which is stable
under RPLC conditions due to the covalent bonding of both oli-
gonucleotide strands,19 a fraction of the intrastrand ELB-21/
Seq-3/Seq-4 adduct dissociated as the ELB-21/Seq-3 intrastrand
adduct (RT 34.2 min; m/z 4609) and the free Seq-4 strand (RT
28.2 min), causing a relative increase in the RT 28.2 min
Seq-4 peak in comparison to the RT 27.1 min Seq-3 peak.
MALDI-TOF MS data (not shown) indicated that the RT
36.3 min peak corresponded to the 2:1 ELB-21/Seq-3 adduct,
with one ELB-21 unit attached to each of the guanine residues
of the 5′-Pu-GAATG-Py binding site (Figure 3b).
Similar experiments were conducted with the self-
complementary 5′-Pu-GATC-Py duplex-3 (Seq5/Seq5) and 5′-Pu-
GATG-Py duplex-4 formed from Seq-6 and Seq-7. The latter
contains an intrastrand binding site as a consequence of the
replacement of cytosine-8 in Seq-5 with a guanine residue.
Figure 4 shows that ELB-21 immediately formed a covalent
adduct (RT 28.7 min) with duplex-3 and the reaction was essen-
tially complete within 3 h. The formation of covalent adducts
between ELB-21 and duplex-4 was evident immediately after
mixing, but the reaction failed to go to completion, even after
24 h (Figure S1, Supplementary data). Thus, in contrast to exper-
iments with the predicted3 pentanucleotide binding sequences
5′-Pu-GAATC-Py (Figure 2) and 5′-Pu-GAATG-Py (Figure 3), ELB-21
preferentially formed interstrand, rather than intrastrand, cross-
links with these tetranucleotide sequences. The experiments
demonstrate that ELB-21 can form cross-linked adducts with
binding sites that are smaller than the ideal binding sequences.
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Figure 2. Formation of ELB-21 interstrand adducts with dsDNA 13-mer duplex-1. Ion-pair RPLC chromatograms of (a) duplex-1, showing denaturation
to Seq-1 (RT 27.1 min) and Seq-2 (RT 27.5 min) under RPLC conditions; (b) immediately (0 h) after mixing of ELB21 with duplex-1 showing the
appearance of interstrand 5′-Pu-GAATC-Py adduct (RT 30.9 min); (c) 3 h after mixing of ELB-21 with duplex-1 showing completion of reaction; (d)
12 h after mixing of ELB-21 with duplex-1. Peaks were characterized using MALDI-TOF MS. Binding sites and cross-linking profiles are indicated
within the appropriate chromatograms in this and subsequent figures.
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Figure 3. Formation of ELB-21 intrastrand adducts with dsDNA 13-mer duplex-2. Ion-pair RPLC chromatograms of (a) duplex-2, showing denaturation
to Seq-3 (RT 27.1 min) and Seq-4 (RT 28.2 min) under RPLC conditions; (b) immediately (0 h) after mixing of ELB-21 with duplex-2, showing the rapid
appearance of intrastrand 5′-Pu-GAATG-Py adduct (RT 29.8 min). Seq-3, which contains the 5′-Pu-GAATG-Py intrastrand binding site, has almost
disappeared; (c) 1 h after mixing of ELB-21 with duplex-2, showing emergence of two minor peaks (RT 32.4 min and RT 36.3 min) in addition to a
major peak (RT 29.8 min). Seq-3 is completely absent, indicating completion of the reaction; (d) 12 h after mixing of ELB-21 with duplex-2. Peaks
were characterized using MALDI-TOF MS.
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Figure 4. Formation of ELB-21 interstrand adducts with dsDNA 12-mer duplex-3. Ion-pair RPLC chromatograms of (a) duplex-3, showing denaturation
to Seq-5 (RT 24.6 min); (b) immediately (0 h) after mixing of ELB-21 with duplex-3, showing the rapid appearance of interstrand 5′-Pu-GATC-Py duplex
adduct (RT 28.7 min); (c) 3 h after mixing of ELB-21 with duplex-3, showing the emergence of a minor peak at RT 34.2 min in addition to the major
peak at RT 28.7 min; (d) 12 h after mixing of ELB-21 with duplex-3. Peaks were characterized using MALDI-TOF MS.
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Finally, to investigate binding to an extended sequence, two
oligonucleotides were designed with one additional A/T base
pair between the two guanines of duplexes 1 and 2. Thus
duplex-5 (Seq-8/Seq-9) offered the extended interstrand
Pu-GAAATC-Py cross-linking site and duplex-6 (Seq-10/Seq-11)
offered the extended intrastrand Pu-GAAATG-Py site (Table 1).
After incubation of ELB-21 with duplex-5, a minor peak at RT
29.8 min and a major peak at RT 33.4 min were apparent
(Figure 5). The identities of the peaks were confirmed by
MALDI-TOF MS; the minor RT 29.8 min peak was found to be
the interstrand ELB-21/Seq-8/Seq-9 adduct and the RT
33.4 min peak contained the co-eluting ELB-21/Seq-8 and
ELB-21/Seq-9 mono-adducts. Adduct formation was not com-
plete even after 24 h incubation and the RT 29.8 min peak
(representing the interstrand cross-linked adduct) remained
as a minor peak throughout the experiment. ELB-21 was
then incubated with the extended intrastrand sequence.
Annealed duplex-6 (Seq-10/Seq-11) containing the sequence
Pu-GAAATG-Py resolved as peaks at RT 26.8 min and RT
28.2 min (Figure 6a), identified by MALDI-TOF MS as Seq-10
and Seq-11, respectively. Incubation of ELB-21 with duplex-6
resulted in the rapid emergence of a major peak at RT
29.8 min and two minor peaks at RT 33.6 min and RT
34.1 min (Figure 6b). As anticipated, the RT 29.8 min peak
was identified as the intrastrand ELB-21/Seq-10/Seq-11
duplex adduct. Both the RT 33.6 min and RT 34.1 min peaks
gave mass values corresponding to ELB-21/Seq-10 adducts.
Based on previous studies with non-nucleophilic inosine-
containing oligonucleotides, which are unable to form covalent
linkages with PBD,18 the RT 33.6 min peak was identified as
the intrastrand cross-linked ELB-21/Seq-10 adduct and the RT
34.1 min peak was identified as the ELB-21/Seq-10 mono-
alkylated adduct. The intrastrand cross-linked duplex adduct
was the most abundant in this experiment (Figure 6).
Thus the rank order of ELB-21 binding sequences was deter-
mined in this study to be 5′-Pu-GAATG-Py≥5′-Pu-GAATC-Py.
5′-Pu-GATC-Py...5′-Pu-GATG-Py5′-Pu-GAAATG-Py5′-Pu-G
AAATC-Py.
Antistaphylococcal effects of ELB-21
ELB-21 displayed potent antibacterial activity against 38 MRSA
isolates, with an MIC90 value of 0.03 mg/L;
1 the MIC for
EMRSA-16 was confirmed as 0.015 mg/L (Table 2). The agent
exhibited potent bactericidal activity against EMRSA-16 and
other bacteria, with an immediate reduction in viable count fol-
lowing exposure to the drug,1 and it induced genes associated
with prophages wSa2 and wSa3,3 common residents within
S. aureus clinical isolates.25 These observations raised the possi-
bility that the bactericidal effect associated with ELB-21 is due to
‘lysis from within’ determined by activation of resident pro-
phages. We therefore examined the effect of ELB-21 on the
viability, optical density and prophage induction of prophage-
carrying and prophage-cured strains of S. aureus in comparison
to MMC, a well-established inducer of prophage.
The addition of ELB-21 at concentrations of 2–4×MIC to 3 h
mid-logarithmic EMRSA-16 cells produced an immediate and
large reduction in viability; at 1×MIC the bactericidal effect
was much less pronounced (Figure 7b). Cell viability began to
decline approximately 1 h after addition of the drug; with
supra-inhibitory concentrations, a threefold reduction in cfu/mL
was evident after 8 h (Figure 7a). Phage release occurred 3 h
after drug exposure and the pfu/mL increased up to 5 h, time-
points which are coincident with maximal reduction in OD600;
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Figure 5. Formation of ELB-21 interstrand adducts with dsDNA 14-mer duplex-5. Ion-pair RPLC chromatograms of (a) duplex-5, showing denaturation
to Seq-8 (RT 00.0 min) and Seq-9 (RT 00.0 min); (b) immediately (0 h) after mixing of ELB-21 with duplex-5, showing the rapid appearance of the
minor interstrand Pu-GAAATC-Py duplex adduct at RT 29.8 min; (c) 4 h after mixing of ELB-21 with duplex-5; (d) 24 h after mixing of ELB-21 with
duplex-5, showing that the interstrand ELB-21/Seq-8/Seq-9 adduct at RT 29.8 min remains as a minor peak. Peaks were characterized using
MALDI-TOF MS.
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phage numbers declined rapidly following this delayed burst
(Figure S2, Supplementary data). Interestingly, more infectious
phage particles were induced by 1×MIC compared with 4×MIC;
only one morphological phage type, typical of the
Siphoviridae,26 was evident after extensive transmission electron
microscopy (TEM) investigation of ELB-21-induced supernatants.
Growth of the surviving fraction of EMRSA-16 cells was evident
after 24 h incubation. The response was comparable to that
induced by MMC (Figure 7c and d), except that recovery of
MMC-exposed bacteria was not evident after 24 h (Figure 7d).
MMC was a far more potent inducer of prophage than ELB-21
(Figure S2, Supplementary data). To further investigate if induc-
tion of prophage contributed wholly or in part to the bactericidal
or lytic profile of ELB-21, we compared the response to ELB-21
exposure of NCTC 8325, a strain carrying wSa2 and wSa3, with
that of its prophage-free derivative RN4220. As shown in
Figure 8, there was a clear difference in the responses of these
two strains to ELB-21 and MMC at concentrations at or above
the MIC (0.015–0.03 and 0.125–0.25 mg/L, respectively). The
immediate reduction in OD600 at 2 h following addition of
supra-inhibitory ELB-21 concentrations (Figure 8a) was far
greater than that found with the more recent clinical isolate
EMRSA-16 (Figure 7a) and was accompanied by a corresponding
immediate reduction in viability (Figure 8b). Similar profiles were
obtained with MMC (Figure 8c and d) and, again, in contrast to
ELB-21, there was no recovery of viability after 24 h incubation
(Figure 8d). Although loss of viability of RN4220 was comparable
to the NCTC 8325 parent strain with both ELB-21 (Figure 8f) and
MMC (Figure 8h), there was no reduction in optical density for
either drug (Figure 8e and g). Thus prophage induction does
not account for killing of the prophage-replete parent NCTC
8325, but bacterial lysis, observed with a proportion of the bac-
teria, appears to be due solely to activation of resident pro-
phages. Exposure to both ELB-21 and MMC resulted in levels of
induction of resident NCTC 8325 prophages comparable to
those found with EMRSA-16 (data not shown).
We have previously shown that the addition of ELB-21 to
logarithmic phase EMRSA-16 cells led to a twofold or greater
change in expression of 184 genes, the large majority of
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Figure 6. Formation of ELB-21 intrastrand adducts with dsDNA 14-mer duplex-6. Ion-pair RPLC chromatograms of (a) duplex-6, showing denaturation
to Seq-10 (RT 26.8 min) and Seq-11 (RT 28.2 min); (b) immediately (0 h) after mixing of ELB-21 with duplex-6, showing the rapid appearance of the
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Table 2. Susceptibility of S. aureus strains to ELB-21 and mitomycin C
(MMC)
Bacterial strain Description
MIC (mg/L)
ELB-21 MMC
EMRSA-16 Hospital-acquired MRSA 0.015 0.03
NCTC 8325 Isolated in 1960 from
sepsis patient
0.015 0.125
RN4220 Prophage-cured derivative
of NCTC 8325
0.03 0.25
RN450 Prophage-cured derivative
of NCTC 8325
0.03 0.25
RN451 RN450 lysogenic for w11 0.03 0.25
RN981 DrecA derivative of RN450 0.00015 0.0075
RN1030 DrecA derivative of RN451 0.000075 0.0075
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which were upregulated;3 almost half were induced prophage
genes as well as genes associated with the SaPI4 pathogen-
icity island. To determine the transcriptional response of
ELB-21 in a prophage-free background, we exposed mid-
logarithmic MH broth-grown RN4220 to the agent at a concen-
tration of 0.5 MIC. One hour after addition of ELB-21, 27 genes
were found to be up-regulated (Table S2, Supplementary data)
and 32 genes down-regulated (Table S3, Supplementary data)
at least twofold compared with drug-free RN4220 cultures. Ten
of the genes activated by exposure to the drug are involved in
DNA damage repair and the pattern of ELB-21-mediated
induction of SOS-associated proteins was comparable to that
induced by MMC. Other ELB-21-activated genes included
small numbers encoding membrane proteins, transporter com-
ponents and metabolic enzymes. No clear pattern of down-
regulation by ELB-21 emerged, with a variety of regulatory,
transport, membrane and metabolic proteins affected
(Table S3), and may reflect specific binding to primary
sequences at subinhibitory concentrations within these genes.
Interestingly, the number of RN4220 genes down-regulated
by the PBD dimer was twice that found with EMRSA-16, an
isolate carrying prophages wSa2 and wSa3. The pattern of
genes with increased expression following exposure to
ELB-21 was markedly similar to that associated with induction
by a subinhibitory concentration of MMC (Table S2), even
though the latter compound is considered to be a less specific
DNA binding agent than PBD dimers such as ELB-21.13 Thus
exposure to MMC at 0.5 MIC resulted in the twofold or
greater up-regulation of 25 genes and down-regulation of 16
(Tables S2 and S3), with a higher degree of complementarity
between ELB-21 and MMC for up-regulated compared with
down-regulated genes. Changes in the expression of eight
genes by ELB-21 and MMC, as determined by microarray
analysis, were validated by qRT–PCR (Table S4, Supplementary
data); there was a high degree of correlation between the two
methods.
That the relative susceptibility of DNA repair-competent sta-
phylococci is critically dependent on induction of the SOS
response was emphasized by large decreases in MIC values for
both DrecA mutant RN1030 and prophage-cured DrecA mutant
RN981; both DrecA mutants were more than 100-fold more sus-
ceptible to ELB-21 than the parent strains (Table 2).
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Figure 7. Response of S. aureus EMRSA-16 to subinhibitory and supra-inhibitory concentrations of ELB-21 and mitomycin C (MMC). ELB-21 (a, b) and
MMC (c, d) were added to mid-logarithmic phase cultures (OD600≈0.1; 3 h), OD600 measured (a, c) and viable numbers determined (b, d): Error bars
represent+1 SD; n¼3.
Rosado et al.
992
(a)
Time (h)
0 2 4 6 8 10 12 14 16 18 20 22 24
0 2 4 6 8 10 12 14 16 18 20 22 24
0 2 4 6 8 10 12 14 16 18 20 22 24 0 2 4 6 8 10 12 14 16 18 20 22 24
0 2 4 6 8 10 12 14 16 18 20 22 240 2 4 6 8 10 12 14 16 18 20 22 24
0 2 4 6 8 10 12 14 16 18 20 22 24
Lo
g 
O
D 6
00
Lo
g 
O
D 6
00
Lo
g 
O
D 6
00
Lo
g 
O
D 6
00
0.01
0.1
1
10 (b)
Time (h)
Time (h) Time (h)
Time (h) Time (h)
Time (h) Time (h)
Lo
g 
cf
u/
m
L
0
1
2
3
4
5
6
7
8
9
10
No drug
0.5 × MIC
1 × MIC
2 × MIC
4 × MIC
(c)
0.01
0.1
1
10 (d)
0 5 10 15 20
Lo
g 
cf
u/
m
L
0
1
2
3
4
5
6
7
8
9
10
(e)
0.01
0.1
1
10 (f)
Lo
g 
cf
u/
m
L
0
1
2
3
4
5
6
7
8
9
10
(g)
0.01
0.1
1
10 (h)
Lo
g 
cf
u/
m
L
0
1
2
3
4
5
6
7
8
9
10
Figure 8. Response of S. aureus NCTC 8325 (a–d) and the prophage-cured derivative RN4220 (e–h) to subinhibitory and supra-inhibitory
concentrations of ELB-21 and mitomycin C (MMC). ELB-21 (a, b, e, f) and MMC (c, d, g, h) were added to mid-logarithmic phase cultures
(OD600≈0.1; 2 h), OD600 measured (a, c, e, g) and viable numbers determined (b, d, f, h). Error bars represent+1 SD; n¼3.
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Discussion
PBD dimers were designed to arrest DNA replication, inhibit
binding of enzymes and transcription factors to DNA and
prevent transcription by stably cross-linking opposing DNA
strands.2,4,27,28 The drugs are shaped to fit the minor groove of
duplex DNA without distortion of the helix and to form covalent
bonds with appropriately spaced guanine residues. The five-
carbon diether linking moiety of ELB-21 facilitates interstrand
tethering of guanines separated by 3 bp, and hydrogen bonds
between the N10 protons of the PBD units and neighbouring
adenine residues provide further sequence selectivity.29 ELB-21
is the most potent antibacterial in this group of compounds
examined to date, displaying bactericidal killing kinetics against
susceptible Gram-positive bacteria and cross-linking DNA in
situ.1,7 However, recent investigation of ELB-21 binding sites
using DNase I footprinting methods identified a range of
further interstrand DNA binding sites both longer and shorter
than the predicted target sequences and indicated that the
drug forms intrastrand as well as interstrand DNA adducts.3
These observations complement those made with SJG-136, a
PBD dimer with a three-carbon diether bridge that recognizes
guanines on opposing DNA strands separated by 2 bp.4 It has
successfully completed phase I clinical trials in patients with
advanced solid tumours;30 this promising, clinically effective
agent has recently been found to form interstrand and intra-
strand adducts with a wider variety of DNA targets than pre-
viously recognized.18 As the nature of the adducts formed
between ELB-21 and dsDNA sequences has implications for its
mode of antibacterial action, the capacity of recombination-
competent bacteria to repair damaged sites on DNA and the
potential for resistance to this class of agent, we investigated
the preferred binding patterns of ELB-21 to short oligonucleotide
target sequences using a new method19 that provides precise,
quantitative kinetic data and mass spectrometric identification
of the adducts formed.
Our study has provided direct evidence that ELB-21 forms
interstrand cross-links at the preferred binding site
5′-Pu-GAATC-Py;2,5 cross-links were evident immediately after
mixing of the drug with duplex DNA and were complete within
3 h (Figure 2), confirming the high affinity of ELB-21 for one of
its designed target sequences. As anticipated from previous foot-
printing studies,3 the drug also avidly cross-links shorter
sequences within duplex DNA, including 5′-Pu-GATC-Py
(Figure 4), one of the main targets for SJG-136.8 The capacity
of ELB-21 to cross-link sequences longer than the preferred
target, such as 5′-Pu-GAAATC-Py (Figure 5), emphasizes the con-
siderable number of potential binding sites that almost certainly
contribute towards the potent antistaphylococcal activity of PBD
dimers such as ELB-21.1,7 The preference of ELB-21 for formation
of the intrastrand adduct Pu-GAATG-Py (Figure 6) over the inter-
strand cross-linking of Pu-GAATC-Py was unexpected and rep-
resents a key finding of this study, along with the capacity of
the drug to slowly form intrastrand adducts with the shorter
sequence 5′-Pu-GATG-Py. The observation that ELB-21 formed
intrastrand adducts with duplex sequences of ideal length for
interstrand cross-linking contrasts with data obtained using
SJG-136;18 this PBD dimer also forms intrastrand adducts, but
preferences are for sequences longer and shorter than the
ideal length interstrand targets. Insights into adduct formation
with SJG-136 were obtained using energy-minimized molecular
models; the agent could be readily accommodated in the
minor groove by participating guanines for both interstrand
and intrastrand adducts but could be accommodated through
binding to extended sequences only at the expense of some dis-
tortion of the DNA helix at the points of attachment.18 We antici-
pate similar effects with ELB-21 that may explain induction of
the RecA-LexA pathway in EMRSA-16 that we have observed in
this and prior3 studies.
We previously determined that exposure of EMRSA-16 to
ELB-21 resulted in a pattern of gene up-regulation indicative of
a DNA damage response with concomitant induction of proph-
age.3 The rapid bactericidal action of the drug was accompanied
by delayed cell lysis that appeared to be due to release of
induced phages, as strains cured of all resident prophages
were rapidly killed, but not lysed, by ELB-21. In accord with
other studies,31,32 a relatively low proportion of the EMRSA-16
population released viable phage particles following drug treat-
ment, as evidenced by lysis of around 5% of bacteria and low
plaque counts of culture supernatants. It is unclear in our
study whether phages are released in delayed fashion from the
non-viable or the viable portion of bacteria in the culture.
Although ELB-21 was designed as a sequence-selective agent
with the capacity to bind to a restricted set of motifs within
target DNA, the response of EMRSA-16 to this agent was
similar to that obtained with the non-selective DNA interactive
agent MMC, suggesting that the antibacterial effects observed
were due to an inadequate response to DNA damage.
Changes in bacterial gene expression following addition of
ELB-21 and MMC to mid-logarithmic S. aureus cultures further
emphasized these common features of the bacterial response.
We have shown3 that exposure of EMRSA-16 to subinhibitory
concentrations of ELB-21 for 1 h elicited the up-regulation of
more than 160 genes, almost half of which were induced proph-
age genes; also prominent among ELB-21-activated genes were
those involved in DNA damage repair and genes encoding toxins
within the SaPI4 pathogenicity island. As the bacterial transcrip-
tion profile is likely to have been influenced in an unpredictable
way by the activation of a large number of prophage genes
and the subsequent release of viable phage particles, we deter-
mined the transcriptional response to ELB-21 and MMC of
S. aureus RN4220. In this prophage-free background, only a
limited number of genes were induced more than twofold, and
the profiles obtained with each agent were remarkably similar.
With ELB-21, the majority encoded components of the DNA
damage repair system and included the positive (RecA; recombi-
nase A) and negative (LexA) regulators of the SOS response and
products of genes in the LexA regulon involved in error-prone
DNA repair.
Induction of RecA by both ELB-21 and MMC in all likelihood
accounts for the central features of the response of S. aureus to
these agents. The extremely high susceptibility of DrecA strains
to ELB-21 and MMC suggests that the bactericidal action of
these agents occurs above the threshold of repair of damaged
DNA, with growth negated by permanently stalled DNA polymer-
ase and bacterial death due to irreparable strand breaks. During
normal bacterial growth, the repressor LexA is bound to a specific
DNA sequence, the SOS box, located in the promoter region of
genes associated with the SOS system such as recA, lexA
and uvrAB and it therefore down-regulates its own expression.
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The consensus sequence for SOS boxes in S. aureus is
CGAACAAATGTTCG (conserved regions shown in bold)33 which,
interestingly, contains potential target sequences for ELB-21 and
other PBD dimers. LexA has high affinity for A-T-rich regions but,
as SOS boxes generally include G-C pairs, the affinity of LexA for
each targeted promoter is variable and this facilitates some
expression of SOS genes in the repressed state. The SOS response
can be induced by stalled replication forks or unrepaired defects
resulting in the formation of ssDNA;34,35 the ATP-dependent
assembly of ssDNA-RecA nucleoprotein filaments engenders
LexA autocleavage and inactivation of the repressor with conse-
quent induction of SOS genes. During an SOS response, some
genesmay be rapidly induced, partly induced or remain repressed
until high or persistent DNA damage has occurred;36 such incre-
mental induction patterns may explain why some SOS genes
remain silent after ELB-21-induced damage. In similar fashion,
ssDNA-RecA filaments mediate autocleavage of phage repressors
such as Cl, inducing phage release by up-regulation of prophage
genes.31,35,37
Some S. aureus virulence proteins, such as b-toxin (Hlb), fibro-
nectin binding protein (Fnb) and staphylokinase (Sak), are
encoded by prophage genes and phage induction is likely to acti-
vate the expression of these virulence effectors.31,34 Indeed,
ELB-21 up-regulates virulence-associated, SaPI4-encoded genes
hlb, tst (toxic shock syndrome toxin-1) and ssp (V8 serine protease)
in EMRSA-16. Antibiotics that de-repress resident staphylococcal
prophages have been shown to induce mobilization and high-
frequency horizontal transmission of co-resident pathogenicity
islands.23,38 Such phage-related chromosomal islands play a
major role in the dissemination of genes that impact human
health and bacterial adaptation to animal hosts39 and may
affect the resolution of infections during the course of therapy
with SOS-inducing chemotherapeutic agents. Further understand-
ing of these complex interactions will aid the selection of che-
motherapeutic agents for the treatment of severe infections in
the human host. Although ELB-21 has the capacity to damage
host cell DNA, it exerts potent antibacterial effects at concen-
trations below its cytotoxicity threshold; wewill describe the selec-
tive toxicity profile of the compound in a future publication.
Although ELB-21 has a toxicity profile that does not bear compari-
son with established antibiotics, the need for agents with the
potential to supplement the current arsenal of antibiotics is so
great that the systemic use of colistin is now commonplace.40
The growing body of clinical data for SJG-136 suggests that PBD
dimers elicit therapeutic effects below the toxicity threshold,
and we will continue to investigate ELB-21 as a potential ‘agent
of last resort’ for severe systemic Gram-positive infections.
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